Your browser doesn't support javascript.
loading
Gut check on diabesity: leveraging gut mechanisms for the treatment of type 2 diabetes and obesity.
Will, Sarah; Hornigold, David C; Baker, David J; Coghlan, Matthew P; Mesquita, Malcolm; Trevaskis, James L; Naylor, Jacqueline.
Afiliação
  • Will S; Cardiovascular and Metabolic Disease, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
  • Hornigold DC; Cardiovascular and Metabolic Disease, MedImmune Ltd, Granta Park, Cambridge CB21 6GH, UK.
  • Baker DJ; Cardiovascular and Metabolic Disease, MedImmune Ltd, Granta Park, Cambridge CB21 6GH, UK.
  • Coghlan MP; R&D Innovation Sourcing, Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Måløv, Denmark.
  • Mesquita M; Cardiovascular and Metabolic Disease, MedImmune Ltd, Granta Park, Cambridge CB21 6GH, UK.
  • Trevaskis JL; Cardiovascular and Metabolic Disease, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.
  • Naylor J; Cardiovascular and Metabolic Disease, MedImmune Ltd, Granta Park, Cambridge CB21 6GH, UK. Electronic address: naylorja@MedImmune.com.
Curr Opin Pharmacol ; 37: 10-15, 2017 12.
Article em En | MEDLINE | ID: mdl-28802873
Gut hormones have long been understood to regulate food intake and metabolism. Bariatric surgery significantly elevates circulating gut hormone levels and is proven to affect acute remission of type 2 diabetes before any weight loss is observed. Subsequent weight loss is accrued over weeks to months but is sustained into the long term. Hence, there exists great enthusiasm to recapitulate these changes in gut hormones in the form of novel combination drugs for type 2 diabetes and obesity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trato Gastrointestinal / Diabetes Mellitus Tipo 2 / Obesidade Limite: Animals / Humans Idioma: En Revista: Curr Opin Pharmacol Assunto da revista: FARMACOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trato Gastrointestinal / Diabetes Mellitus Tipo 2 / Obesidade Limite: Animals / Humans Idioma: En Revista: Curr Opin Pharmacol Assunto da revista: FARMACOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos